Daftar Referensi :
1. Freeman AM, Matto P. Adenopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK513250
2. McClain KL. Peripheral lymphadenopathy in Children: Etiology. UpToDate. 2022.
https://www.uptodate.com/contents/peripheral-lymphadenopathy-in-children-etiology.
3. McClain KL. Peripheral lymphadenopathy in Children: Evaluation and diagnostic approach. UpToDate. 2022. https://www.uptodate.com/contents/peripheral-lymphadenopathy-in-children-evaluation-and-diagnostic-approach.
4. Mohseni A et al. Peripheral Lymphadenopathy: Approach and Diagnostic Tools. Iran J Med Sci. 2014 Mar;39(2 Suppl):158-70. PubMed. PMID: 24753638.
5. Gaddey HL, Riegel AM. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2016;94(11):896-903. PMID: 27929264.
6. Ferrer RL. Evaluation of peripheral lymphadenopathy in adults. UpToDate. 2022.
https://www.uptodate.com/contents/evaluation-of-peripheral-lymphadenopathy-in-adults.
7. Gooding, R., Millar, A., & Bradding, P. (2017). Lymphoid follicles in chronic obstructive pulmonary disease and lung cancer. Thorax, 72(5), 475-477.
8. Swerdlow, S. H., Campo, E., Harris, N. L., Jaffe, E. S., Pileri, S. A., Stein, H., ... & Staudt, L. M. (2017). WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer.
9. Vojdani, A., Vojdani, E., & Cooper, E. (2002). Antibodies to Myelin Basic Protein, Neuron-Specific Enolase, and S100b in Cerebrospinal Fluid of Patients with Multiple Sclerosis, Other Inflammatory Neurological Diseases and Controls. Journal of
Autoimmune Diseases, 1, 1-6.
10. Hauben, M., Hung, E., & Hsieh, W. H. (2019). The Proportional Reporting Ratio (PRR) for Signal Detection in Pharmacovigilance. Drug Safety, 42(2), 85-94.
11. Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and Reports, 64(RR-03), 1-137.
12. Dinarello, C. A. (2018). Overview of the IL-1 family in innate inflammation and acquired immunity. Immunological Reviews, 281(1), 8-27.
